Kozak & Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.5K | Hold |
480
| – | – | 0.01% | 170 |
|
|
2025
Q1 | $31.7K | Hold |
480
| – | – | 0.01% | 147 |
|
|
2024
Q4 | $42.1K | Hold |
480
| – | – | 0.01% | 139 |
|
|
2024
Q3 | $56.7K | Hold |
480
| – | – | 0.01% | 126 |
|
|
2024
Q2 | $66.7K | Hold |
480
| – | – | 0.02% | 113 |
|
|
2024
Q1 | $63.9K | Sell |
480
-406
| -46% | -$54K | 0.02% | 118 |
|
|
2023
Q4 | $94.2K | Hold |
886
| – | – | 0.03% | 106 |
|
|
2023
Q3 | $81.6K | Hold |
886
| – | – | 0.03% | 111 |
|
|
2023
Q2 | $70.6K | Hold |
886
| – | – | 0.03% | 119 |
|
|
2023
Q1 | $70.5K | Hold |
886
| – | – | 0.03% | 122 |
|
|
2022
Q4 | $60K | Hold |
886
| – | – | 0.03% | 134 |
|
|
2022
Q3 | $46K | Hold |
886
| – | – | 0.03% | 147 |
|
|
2022
Q2 | $49K | Hold |
886
| – | – | 0.03% | 147 |
|
|
2022
Q1 | $46K | Hold |
886
| – | – | 0.03% | 163 |
|
|
2021
Q4 | $46K | Hold |
886
| – | – | 0.03% | 163 |
|
|
2021
Q3 | $50K | Buy |
+886
| New | +$50K | 0.03% | 156 |
|